Finland, the Netherlands and Sweden have the lowest prices for mobile phone calls among OECD countries, according to the latest OECD Communications Outlook. The highest were found in Canada, Spain and the United States.
This publication assesses the current status of Korea’s innovation system and policies, and identifies where and how the government should focus its efforts to improve the country’s innovation capabilities.
This conference, which took place in Paris on 15-17 July 2009, will significantly contribute to accelerating OECD’s current efforts for fostering “green” and innovation-led growth in nanotechnology.
Given the current low level of nanotechnology monitoring, the objective of this paper is to provide a comprehensive overview of nanotechnology developments globally through a systematic and critical analysis of available and comparable indicators and statistics.
In his remarks delivered at the International Economic Forum of the Americas, Mr. Gurría affirmed that innovation will be the key to foster economic growth and to tackle the major global and social challenges of our time: persistent poverty, unemployment, climate change, water management, and health care.
A new OECD report, The Bioeconomy to 2030: Designing a Policy Agenda, examines the role of biotechnology in the global economy over the next two decades and outlines policies that could maximize its benefits.
An international panel of experts mandated by the Icelandic government recommends consolidation of the universities and revitalized governance and support measures to build on Iceland’s world-class science base. (May 2009)
This report warns that innovation risks being hit hard by the economic crisis as the capital to finance it grows scarce.
English, , 388kb
Higher education in Iceland has grown and diversified more quickly and more recently than almost any other OECD country, and circumstances dictate that Iceland must now adapt its system more quickly than others as well.
English, , 2,570kb
The 2009 edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.